MEROPENEM OrPha subst seche 500 mg 10 pce

7680700850025 CH-70085 J01DH02 08.01.25

Active substances:

No images available

Details

Product number
7008501
CPT
-
Packaging group
10
Unit
Durchstechflasche(n)
Composition
Praeparatio sicca: meropenemum 500 mg ut meropenemum trihydricum, natrii carbonas, pro vitro corresp. natrium 45.05 mg.

Articles (1)

Meropenem OrPha 500 mg, Pulver zur Herstellung einer Injektions-/Infusionslösung
Pulver
10
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
14/07/2026
Professional SmPC
Français
14/07/2026
Professional SmPC
Italien
14/07/2026

Detailed composition

Substance Quantity Type Category
meropenemum
500.0 MG Substance Wirkstoff (Principe actif)
meropenemum trihydricum
- Substance WIZUS
natrii carbonas
- Substance HNIDK
natrium
45.05 MG Substance HBESI

Authorization holder

OrPha Swiss GmbH

8700 Küsnacht ZH

Authorization information

Swissmedic authorization number
70085
Drug name
Meropenem OrPha, Pulver zur Herstellung einer Injektions-/Infusionslösung
Galenic form
PULVII
ATC Code
J01DH02
Authorization status
Z
Dispensation category
A
First authorization
15/12/2025
Authorization expiration date
14/12/2030
IT number
08.01.25
Domain
Human medicine
Field of application
Infektionskrankheiten

Packaging details

Description (FR)
MEROPENEM OrPha subst seche 500 mg 10 pce
Description (DE)
MEROPENEM OrPha Trockensub 500 mg 10 Stk
Market launch
01/06/2026
Narcotic (BTM)
No

Available generics

Meropenem Fresenius i.v., Pulver zur Herstellung einer Injektions-/Infusionslösung
CHF 137.95
View
Meropenem Fresenius i.v., Pulver zur Herstellung einer Injektions-/Infusionslösung
CHF 250.80
View
Meropenem Labatec i.v., poudre pour injection ou perfusion
CHF 137.90
View
Meropenem Labatec i.v., poudre pour injection ou perfusion
CHF 250.80
View

Other packaging sizes

MEROPENEM OrPha subst seche 1 g 10 pce
10 DUR
View
Buy us a coffee Explore the data